The efficacy and safety of rituximab in treating childhood refractory nephrotic syndrome: A meta-analysis

Rituximab is considered to be a promising drug for treating childhood refractory nephrotic syndrome. However, the efficacy and safety of rituximab in treating childhood refractory nephrotic syndrome remain inconclusive. This meta-analysis aimed to investigate the efficacy and safety of rituximab tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Zhihong, Liao, Guixiang, Li, Yongqiang, Zhou, Shulu, Zou, Hequn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4314653/
https://www.ncbi.nlm.nih.gov/pubmed/25645999
http://dx.doi.org/10.1038/srep08219

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4314653/
https://www.ncbi.nlm.nih.gov/pubmed/25645999
http://dx.doi.org/10.1038/srep08219

Ejemplares similares